Rheumatol Int DOI 10.1007/s00296-015-3264-7

Rheumatology INTERNATIONAL

ERRATUM

Erratum to: Safety of allopurinol compared with other urate‑lowering drugs in patients with gout: a systematic review and meta‑analysis Isabel Castrejon1 · Esther Toledano2 · María Piedad Rosario3 · Estíbaliz Loza4 · Fernando Pérez‑Ruiz5 · Loreto Carmona4 

© Springer-Verlag Berlin Heidelberg 2015

Erratum to: Rheumatol Int DOI 10.1007/s00296‑014‑3189‑6 The Acknowledgement was incorrectly presented in the original publication. Menarini had no role in the study design, literature search, data collection, data analysis, data interpretation or writing of this report and had been included erroneously. The correct information should read. Acknowledgments  This work was supported by the Spanish Foundation of Rheumatology.

The online version of the original article can be found under doi:10.1007/s00296-014-3189-6. * Isabel Castrejon [email protected] 1

Division of Rheumatology, Rush University Medical Center, 1611 West Harrison Street, Suite 510, Chicago, IL 60612, USA

2

Department of Rheumatology, Hospital Clínico San Carlos, Madrid, Spain

3

Research Unit, Spanish Society of Rheumatology, Madrid, Spain

4

Institute for Musculoskeletal Health, Madrid, Spain

5

Department of Rheumatology, Hospital Universitario Cruces, Baracaldo, Spain





13

Erratum to: Safety of allopurinol compared with other urate-lowering drugs in patients with gout: a systematic review and meta-analysis.

Erratum to: Safety of allopurinol compared with other urate-lowering drugs in patients with gout: a systematic review and meta-analysis. - PDF Download Free
355KB Sizes 2 Downloads 6 Views